期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

CAG方案治疗高危组急性髓细胞白血病临床疗效观察 被引量：2

暂未订购
导出
摘要 目的观察CAG方案治疗高危组急性髓细胞白血病(AML)临床疗效及副反应。方法对42例高危组AML采用CAG方案诱导治疗:吡柔比星(THP)10mg,静脉点滴,第1-8d;Ara-c 25mg,肌肉注射,每12h一次,第1-14d;G-CSF200μg/m2,第1-14d,每日肌注阿糖胞苷前皮下注射。所有患者均完成1疗程后评估。结果 20例获得CR(47.6%),17例达PR(40.4%),5例NR(12%),总有效率达88%,化疗不良反应主要为粒细胞减少,血小板减少,继续感染及发热等骨髓抑制表现,大多数患者均能耐受。结论 CAG方案治疗高危组AML临床疗效肯定,毒副反应少,值得临床推广应用。
作者 黄先豹 杨赣萍 陈艳 李菲 刘茂发 陈国安
机构地区 南昌大学第一属医院
出处 《江西医药》 CAS 2011年第5期425-426,共2页 Jiangxi Medical Journal
关键词 白血病 急性 粒细胞集落刺激因子 阿糖胞苷 吡柔比星 化疗 预激
分类号 R733.7 [医药卫生—肿瘤]
  • 相关文献

参考文献4

二级参考文献14

  • 1刘艳艳,张莉,魏旭东,汪萍,宋永平.预激疗法治疗难治性急性髓细胞白血病疗效分析[J].临床血液学杂志,2005,18(1):19-21. 被引量：16
  • 2MAIWen-yuan LINMao-fang.Induction of apoptosis by homoharringtonine in G1 phase human chronic myeloid leukemic cells[J].Chinese Medical Journal,2005(6):487-492. 被引量：22
  • 3陆红梅,张海燕,吉布强.化疗前应用G-CSF治疗急性髓细胞白血病的临床探讨[J].白血病．淋巴瘤,2005,14(4):233-234. 被引量：4
  • 4庞丽萍,魏颖慧,聂李平,许蕾,王小花,孟庆祥.粒细胞集落刺激因子影响白血病细胞增生的研究[J].白血病．淋巴瘤,2007,16(1):52-53. 被引量：1
  • 5Davis CL, Rohatiner AZS, Lim J ,et al. The management of recurrent acute myelogenus leukaemia at a single center over a 15-year period. Br J Haematol, 1998,83:404-411.
  • 6Yamada K, Furusawa S, Saito K, et al. Concurrent use of granulocyte colony stimulation factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia:a pilot study. Leukemia, 1995,9:10-14.
  • 7Lowenberg B,van Putten W,Theobald M,et al. Effect of priming with granulocyte colony stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. New Engl J Med, 2003,349:743-752.
  • 8Harouseau JL, Wu DP. The use of GM-CSF and G CSF in the treament of acute leukemia. Leuk Lymphoma, 1995,18:405-412.
  • 9Amuguleng B, Hiroshi K, Mitsuo H, et al. Priming with G-CSF effectively enhances low-lose Ara-C induced in vivo apoptosis in myeloid leukemia cells. Exp Hematol, 2003,27 (2) : 259-265.
  • 10Katagiri T, Miyawa K, Nishimaki J, et al. Combination of granulocyte colony-stimulating factor and low-dose cytosine arabinoside further enhances myeloid differentiation in leukemia cells in vitro.Leuk Lymophoma,2002,39(12):173-184.

共引文献27

同被引文献21

  • 1沈玲华,沈权,陈明忠.中剂量阿糖胞苷早期强化治疗急性髓系白血病疗效观察[J].江西医药,2005,40(10):636-637. 被引量：3
  • 2Avramis VI, Biener R, Krailo M,et al. Biochemical pharmacology ofhigh dose 1 -beta -D -arabinofuranosylcytosine in childhood acuteleukemia[J]. Cancer Res, 1987,47(12):6786-6792.
  • 3PlunkettW, Liliemark J0,Estey E,et al. Saturation of ara-CTP ac-cumulation during high -dose ara-C therapy : pharmacologic ratio-nale for intermediate -dose ara-C [J]. Semin Oncol,1987,14(6):159-166.
  • 4ClarkeML,Mackey JR,Baldwin SA,et al. The role of membranetransporters in cellular resistance to anticancer nucleoside drugs[J].Cancer Treat Res,2002,112: 27-47.
  • 5MyersSN,Goyal RK’Roy JD,et al. Functional single nucleotidepolymorphism haplotypes in the human equilibrative nucleosidetransportei{J]. Pharmacogenetics and Genomics,2006,16(5) : 315-20.
  • 6GusellaM ,Pasini F, Bolzonella C ,et al. Equilibrative nucleosidetransporter 1 genotype, cytidine deaminase activity and age predictgemcitabine plasma clearance in patients with solid tumours[J]. BrJ Clin Pharmacol,2011,71 ⑶-.437-44.
  • 7PodgorskaM,Kocbuch K,Pawelczyk T. Recent advances in studieson biochemical and structural p roperties of equilibrative and con-centrative nucleoside transporters [J]. Acta B iochim Pol,2005,52(4): 749-758.
  • 8GalmariniCM, Thomas X, Calvo F,et al. In vivo mechanisms ofresistance to cytarabine in acute myeloid leukaemia [J]. Br JHaematol,2002,117(4) : 860亨868.
  • 9TakagakiK, Katsuma S, Kaminishi Y,et al. Gene -expression pro-filing reveals down -regulation of equilibrative nucleoside trans-porter 1(ENT1) in Ara-C-resistant CCRF-CEM-derived cells[J]. JBiochem, 2004,136(5) :733-40.
  • 10IHubeek, RW Stam, GJ Peters, et al. The human equilibrative nu-cleoside transporter 1 mediates in vitro cytarabine sensitivity inchildhood acute myeloid [J]. Leukaemia. British J Cancer,2005,93:1388-1394.

引证文献2

二级引证文献3

江西医药
2011年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部